TY - JOUR
T1 - Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis
AU - Suzuki, Naoki
AU - Mizuno, Hideki
AU - Warita, Hitoshi
AU - Takeda, Shin'ichi
AU - Itoyama, Yasuto
AU - Aoki, Masashi
N1 - Funding Information:
This work was supported by Research grants from Nervous and Mental disorders (20B-13), Research on Measures for Intractable Diseases, Research on Psychiatric and Neurological Diseases and Mental Health from the Japanese Ministry of Health Labor and Welfare , Grants-in-Aids for Scientific Research (C: 19590977, 21591070) and Grants-in-Aids for Young Scientist (19890016) from the Japanese Ministry of Education, Culture, Sports, Science and Technology .
PY - 2010/7/15
Y1 - 2010/7/15
N2 - Previously, we demonstrated that neuronal nitric oxide synthase (nNOS) is activated and promotes muscle atrophy in skeletal muscle during tail suspension, a model of unloading and denervation. Here, we examined patients with amyotrophic lateral sclerosis (ALS) and mutant (H46R) SOD1 transgenic (Tg) mice model using immunohistochemistry, Western blotting and real time PCR. We found cytoplasmic nNOS staining of angulated muscle fibers in patients with ALS. We also examined mutant SOD1 Tg mice and found cytoplasmic nNOS staining even before the onset of clinical muscle atrophy. In the Tg mice, nNOS was largely extracted with 100 mM NaCl and barely detected in the pellet fraction, suggesting fragile anchoring of nNOS to the sarcolemma. We also showed an elevated expression of atrogin-1, key molecules in muscle atrophy at the end stage. A common nNOS dislocation/atrogin-1/muscle atrophy pathway among tail suspension, denervation and ALS is suggested. nNOS modulation therapy may be beneficial in several types of muscle atrophy.
AB - Previously, we demonstrated that neuronal nitric oxide synthase (nNOS) is activated and promotes muscle atrophy in skeletal muscle during tail suspension, a model of unloading and denervation. Here, we examined patients with amyotrophic lateral sclerosis (ALS) and mutant (H46R) SOD1 transgenic (Tg) mice model using immunohistochemistry, Western blotting and real time PCR. We found cytoplasmic nNOS staining of angulated muscle fibers in patients with ALS. We also examined mutant SOD1 Tg mice and found cytoplasmic nNOS staining even before the onset of clinical muscle atrophy. In the Tg mice, nNOS was largely extracted with 100 mM NaCl and barely detected in the pellet fraction, suggesting fragile anchoring of nNOS to the sarcolemma. We also showed an elevated expression of atrogin-1, key molecules in muscle atrophy at the end stage. A common nNOS dislocation/atrogin-1/muscle atrophy pathway among tail suspension, denervation and ALS is suggested. nNOS modulation therapy may be beneficial in several types of muscle atrophy.
KW - Amyotrophic lateral sclerosis (ALS)
KW - Motor neuron disease (MND)
KW - Muscle atrophy
KW - Neuronal nitric oxide synthase (nNOS)
KW - Superoxide dismutase (SOD1)
UR - http://www.scopus.com/inward/record.url?scp=77953287436&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953287436&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2010.03.022
DO - 10.1016/j.jns.2010.03.022
M3 - Article
C2 - 20435320
AN - SCOPUS:77953287436
SN - 0022-510X
VL - 294
SP - 95
EP - 101
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
IS - 1-2
ER -